INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 66 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2016. The put-call ratio across all filers is 21.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,353,000 | -35.9% | 798,251 | +3.7% | 0.00% | -100.0% |
| Q3 2016 | $5,233,000 | +18.1% | 769,545 | +0.4% | 0.00% | 0.0% |
| Q2 2016 | $4,432,000 | -13.4% | 766,803 | +4.6% | 0.00% | 0.0% |
| Q1 2016 | $5,118,000 | +7.2% | 733,230 | +10.6% | 0.00% | 0.0% |
| Q4 2015 | $4,774,000 | -1.4% | 663,035 | +18.0% | 0.00% | 0.0% |
| Q3 2015 | $4,843,000 | -4.6% | 561,876 | +78.8% | 0.00% | 0.0% |
| Q2 2015 | $5,076,000 | – | 314,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|